Details for Patent: 12,678,405
Which drugs does patent 12,678,405 protect, and when does it expire?
Patent 12,678,405 protects VYSCOXA and is included in one NDA.
Summary for Patent: 12,678,405
| Title: | Oral liquid compositions of celecoxib |
| Abstract: | Liquid pharmaceutical compositions, including suspensions, of celecoxib are provided herein. Methods of preparing the liquid pharmaceutical compositions and methods of using the compositions to treat diseases or disorders are also provided. Methods of determining the dissolution profile of liquid pharmaceutical compositions containing celecoxib are also provided. |
| Inventor(s): | H. Greg Thomas, Sara Pennington, Roy W. Bryant |
| Assignee: | Codacose Inc , CODADOSE Inc , Kiel Laboratories Inc |
| Application Number: | US19/331,880 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 12,678,405
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carwin Pharm Assoc | VYSCOXA | celecoxib | SUSPENSION;ORAL | 211759-001 | Jul 29, 2025 | RX | Yes | Yes | 12,678,405 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
